These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11765521)

  • 1. What will replace the tech economy?
    Davis S; Meyer C
    Time; 2000 May; 155(21):76-7. PubMed ID: 11765521
    [No Abstract]   [Full Text] [Related]  

  • 2. Public biotechnology 2001--the numbers.
    Lähteenmäki R; Fletcher L
    Nat Biotechnol; 2002 Jun; 20(6):551-5. PubMed ID: 12042853
    [No Abstract]   [Full Text] [Related]  

  • 3. Public biotechnology 2005--the numbers.
    Lähteenmäki R; Lawrence S
    Nat Biotechnol; 2006 Jun; 24(6):625-34. PubMed ID: 16763588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2007--a banner year for biotech.
    Lawrence S
    Nat Biotechnol; 2008 Feb; 26(2):150. PubMed ID: 18259162
    [No Abstract]   [Full Text] [Related]  

  • 5. State of biotech sector--2005.
    Lawrence S
    Nat Biotechnol; 2006 Jun; 24(6):603. PubMed ID: 16763577
    [No Abstract]   [Full Text] [Related]  

  • 6. The biotechnology bubble machine.
    Rasnick D
    Nat Biotechnol; 2003 Apr; 21(4):355-6. PubMed ID: 12665813
    [No Abstract]   [Full Text] [Related]  

  • 7. Public biotechnology 2002--the numbers.
    Lähteenmäki R; DeFrancesco L
    Nat Biotechnol; 2003 Jun; 21(6):607-12. PubMed ID: 12776143
    [No Abstract]   [Full Text] [Related]  

  • 8. Public markets show signs of life.
    Mitchell P
    Nat Biotechnol; 2003 Aug; 21(8):833-4. PubMed ID: 12894181
    [No Abstract]   [Full Text] [Related]  

  • 9. Hydrocarbons and renewable energy.
    Ringpfeil M
    Nat Biotechnol; 2004 Sep; 22(9):1077. PubMed ID: 15340466
    [No Abstract]   [Full Text] [Related]  

  • 10. White biotechnology: ready to partner and invest in.
    Kircher M
    Biotechnol J; 2006; 1(7-8):787-94. PubMed ID: 16897821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Commercializing nanotechnology.
    Mazzola L
    Nat Biotechnol; 2003 Oct; 21(10):1137-43. PubMed ID: 14520392
    [No Abstract]   [Full Text] [Related]  

  • 12. Industry trends. Biotechnology in 1998 and beyond.
    Persidis A
    Nat Biotechnol; 1998 Dec; 16(13):1378-9. PubMed ID: 9853624
    [No Abstract]   [Full Text] [Related]  

  • 13. Editorial: Biotech in Russia--Phoenix reborn from the ashes.
    Rabinovich M
    Biotechnol J; 2007 Jul; 2(7):771. PubMed ID: 17615595
    [No Abstract]   [Full Text] [Related]  

  • 14. Private biotech 2004--the numbers.
    Hodgson J
    Nat Biotechnol; 2006 Jun; 24(6):635-41. PubMed ID: 16763589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Special: biotech in Russia.
    Rabinovich M; Burghardt N; Gorzka G; Kudryashev M; Leonov A; Konov A
    Biotechnol J; 2007 Jul; 2(7):775-89. PubMed ID: 17615597
    [No Abstract]   [Full Text] [Related]  

  • 16. The US biotechnology industry: an analysis of trends.
    Dibner MD
    Aust J Biotechnol; 1988 Sep; 2(2):129-32. PubMed ID: 2485326
    [No Abstract]   [Full Text] [Related]  

  • 17. Public biotech 2006 - the numbers.
    Lähteenmäki R; Lawrence S
    Nat Biotechnol; 2007 Jul; 25(7):729-37. PubMed ID: 17621294
    [No Abstract]   [Full Text] [Related]  

  • 18. Cementing links between industry and the university.
    Jennings R
    Nat Biotechnol; 1998 May; 16 Suppl():35-6. PubMed ID: 9591263
    [No Abstract]   [Full Text] [Related]  

  • 19. Research interactions between industry and academia: a corporate perspective.
    Citron P
    Physiologist; 1996 Jun; 39(3):81, 90-2. PubMed ID: 16764116
    [No Abstract]   [Full Text] [Related]  

  • 20. The German MedTech industry in 2007.
    Schmitt JM; Beeres M
    Med Device Technol; 2007; 18(7):56. PubMed ID: 18075138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.